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approach toward defining a truly objective diagnostic criterion. 
In fact, a recent review has asked if changes in brain rhythms may 
be used as an objective diagnostic tool, but concluded “not yet” 
(Galderisi et al., 2009) due partly to the variety in methods used 
in the studies. Indeed, this is the general conclusion with respect 
to the search for biomarkers whether based on chemical analysis 
of plasma (Domenici et al., 2010), fMRI (Kim et al., 2003), or elec-
trophysiology (Buchsbaum, 2009; Clark et al., 2009; Ferreira and 
Busatto, 2010) for other major categories of psychiatric disorders 
in addition to schizophrenia. The emergence of an interest in brain 
rhythms has paralleled the development of computational tools for 
the analysis of oscillatory dynamics using time–frequency analysis 
(Rudin, 1962) and an understanding of the generation of oscilla-
tions by single neurons (Llinas, 1988).
The present work tests the hypothesis that a decisive factor in 
schizophrenia and other psychiatric disorders is the generation of 
abnormal recurrent neuronal activation that is evidenced by abnor-
mal thalamocortical rhythm epiphenomena, i.e., a thalamocortical 
dysrhythmia (TCD). This assertion is based on an understanding 
of the intrinsic oscillatory properties of thalamic neurons (Jahnsen 
and Llinas, 1984; Llinas, 1988; Steriade and Llinas, 1988; Jeanmonod 
et al., 1996) thalamocortical anatomy (Jones, 1998), and biochemi-
cal influences on the thalamocortical circuit (Behrendt, 2006).
Included in this study are groups of patients with obsessive–
compulsive disorder (OCD) and major depressive disorder (DD) 
that were sent to our center for magnetoencephalography (MEG) 
scans of spontaneous brain activity. They are included here to 
extend our study to other psychiatric disorders. This is a pilot study 
in which we investigated whether this approach would warrant an 
in depth study.
IntroductIon
Schizophrenia, called the paradigmatic illness of psychiatry (Sadock 
et al., 2009) was recognized as a medical ailment in antiquity. 
Indeed, symptoms that are now delineated in the latest Diagnostic 
and Statistical Manual of Mental Disorders (DSM) can be found in 
writings from ancient Greece (Hippocrates 460–377 BC). From its 
inception in the nineteenth century the formal study of schizophrenia 
as a separate diagnostic entity has been the subject of intricate theo-
rization. From a strict scientific perspective its pathophysiology has 
closely followed advances in neuroscience and in the technology it 
wields. The goal of such research has, for the most part, been directed 
toward understanding the basic pathophysiology of the disorder in 
the hope of finding appropriate treatments. More recently, emphasis 
has expanded toward defining objective diagnostic tools that may 
help delineate the nature of the dysfunction on basic scientific terms.
With respect to understanding the pathophysiology of schizo-
phrenia, until recently, theories have belonged to one of two broad 
categories, morphological in the sense of neuropathology (Segall 
et al., 2009; Skudlarski et al., 2010; White et al., 2011) or biochemical 
focusing on particular neurotransmitter systems (Tsai and Coyle, 
2002; Gordon, 2010; Marek et al., 2010; Seeman, 2010). Although 
electrophysiological abnormalities have long been recognized in 
schizophrenia patients, it is only recently that a third category has 
emerged. This may be called electrophysiological or oscillatory. 
This theory is based on the finding of abnormal brain oscillations 
in patients at rest or while performing a task and is the subject of 
a journal issue (Ford and Mathalon, 2008) and a recent review 
(Uhlhaas and Singer, 2010). The approach is integrative in that it 
incorporates elements of the other two categories (Gonzalez-Burgos 
and Lewis, 2008). This novel troika promises a more integrated 
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MaterIals and Methods
The database for this study comprised 11 women and 19 men (15–
64 years of age, mean, SEM 40.5 ± 2.7) referred to us having been 
diagnosed with a psychiatric disorder according to DSM-IV crite-
ria (American Psychiatric Association, 2000). The control group 
comprised 8 healthy women and 10 healthy men (23–67 years of 
age, mean, SEM 33.5 ± 3.4 years) with no reported neurological 
or psychiatric history. The NYU Institutional Review Board and 
Bellevue Hospital Research Protocol Review Group approved the 
study and an informed written consent was obtained from all sub-
jects before the MEG recordings.
MeG data acquIsItIon
All MEG recordings were carried out in a mu-metal magnetically 
shielded room using our original 148-channels (4-D Neuroimaging) 
whole-head magnetometer system while the person was supine. (For 
comparison, one schizophrenia spectrum disorder (SSD), OCD, and 
DD patient was imaged with our new 275-channel (CTF System) 
in the sitting position.) A set of three MEG recordings (filtered 
1–100 Hz; sampling rate 508 Hz), each lasting 7-min, was made 
from each person. Two sets of recordings were made with the eyes 
closed (EC) and one with the eyes open (EO). The location of the 
head was monitored during the recordings using electrodes placed 
at three standard fiducial marker points (left and right preauricular 
points, and the nasion). The head shape, including the location of 
the three fiducial markers, was obtained for each subject using a 3-D 
tracking system by moving a stylus to each fiducial point and over 
the surface of the head (Fastrak, Polhemus, Colchester, VT, USA).
MeG data analysIs of power spectra
Electrocardiograms were recorded off-line for heartbeat-artifact 
minimization. A channel-by-channel minimization of cardiac and 
distant-source artifacts was carried out following our published 
protocols (Schulman et al., 2005). All raw data were inspected visu-
ally and movement artifacts (as may occur during swallowing or eye 
blinking) or periods of large amplitude slow waves were eliminated 
from further analysis. Since we were interested in identifying abnor-
mal brain rhythms in patients with neuropsychiatric disorders, the 
energy of the MEG signal as a function of frequency, which is the 
power spectral density, was calculated for each recording session. 
We used a multi-taper approach, which provides reduced-variance 
calculations of frequency (Llinas et al., 1999; Mitra and Pesaran, 
1999). To quantify the relative spectral power distribution among 
groups, the mean spectral energy (MSE) was calculated in five 
frequency bands; theta (4–7.9 Hz), alpha (8–11.9 Hz), low beta 
(12–17.9 Hz), high beta (18–29.9 Hz), gamma (30–69.9 Hz) by 
dividing the total spectral power in a band by the bandwidth in 
Hertz (Makela et al., 1998). Multiple-response logistic regression 
was performed to check the age effect on diagnosis group. No effect 
of age was found. Then the absolute MSE was compared by t-tests 
between controls and each patient group, separately. Bonferroni 
adjustment was used to adjust the p-value in the process of multi-
ple comparisons. SAS9.2 (SAS Institute Inc., Cary, NC, USA) was 
used for statistical analysis and p < 0.05 was considered significant.
For classification of individual subjects into patient or control 
group, classical linear discriminant analysis (DA) was carried out 
with spectral band power as feature vector. In order to summarize 
the data and because spectra from all electrodes had a similar shape 
and scale, we averaged the log-transformed spectra of all MEG sen-
sors for each subject. The DA determines the linear combination of 
parameters that best separate two groups, in the sense that it maxi-
mizes the “between-to-within” variance ratio. Each subject was then 
assigned to the closest group based on this linear combination. As 
the feature vector for DA was the MSE in the five frequency bands.
MeG Independent coMponent analysIs
Localization of the site of origin of the brain’s rhythmic activity 
recorded with the EC was implemented for both patients and con-
trols using independent component analysis (ICA). ICA decom-
poses the MEG data into spatially stationary components that are 
independent of each other. We used the Infomax EEGLab algorithm 
(Makeig et al., 1997). For each recording, this method generated a 
set of independent components (ICs) that were ranked according 
to the MEG variance accounted for by each component. Those 
with the lowest order of variance have the largest projection to the 
scalp and make the largest contribution to the signal. Results from 
spatial ICA provided 148 ICs for each recording (the same number 
as sensors). The first 50 ICs make the largest contribution to the 
signal and were examined in detail.
Selection of independent components
For each subject, 10–12 ICs were selected for localization. These IC 
met the following criteria; (1) the frequency of the IC corresponded 
to a dominant peak in the power spectrum of the patients, (2) the 
sensor distribution of the IC had a dipolar magnetic configuration, 
and (3) the component had a low variance (IC1–40). Some ICs was 
selected on the basis of the presence of low-frequency activity in the 
theta (4–8 Hz) frequency range. Such low-frequency activity is not 
typical of healthy adults and we asked if such activity was present 
in neuropsychiatric patients. Some ICs were selected on the basis of 
the presence of activity in the alpha frequency range (8–11.9 Hz). 
Alpha activity is the dominant activity in awake healthy adults 
(Nunez et al., 2001). This allowed us to ascertain if such normal 
activity was present in neuropsychiatric patients and if its localiza-
tion was similar to that of healthy controls.
Localization of independent components
Each selected component in all the patients and in 10 of the con-
trols was localized onto a population-average T1-weighted MRI 
using the information from the fiducial markers and head shape 
as described in Schulman et al. (2005). Concerning visualization, 
results were smoothed with a 3-D Gaussian kernel and linearly 
interpolated on the reconstructed gray-matter surface of a high 
resolution population-averaged MRI previously segmented into 
gray and white matter with the FreeSurfer software package (Fischl 
et al., 2002). Results were projected onto partially inflated brains. 
Matlab (The Mathworks, Natick, MA, USA) and custom in-house 
software were used for all analyses. For illustration, one representa-
tive theta IC and one representative alpha IC were selected for 
each patient and for 10 of the controls. The average localization 
for each group was then obtained by squaring current values to 
provide directionless units of power, normalizing the power values 
for all subjects, and averaging the spatial scaling factors. Using these 
values, the averaged data was re-plotted on a standardized brain.
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symptoms. Twenty-three of the patients were taking one or more of 
the following medications: antidepressant (16), anticonvulsant (9), 
atypical neuroleptic (8), benzodiazepine (4), lithium (3), anticho-
linergic (1), clonidine (1), typical neuroleptic (1), stimulant (1). The 
global assessment of functioning (GAF) scale was accessed in 17 of 
the patients. The demographics for the control group are given in 
Table 2; none of the controls were taking psychoactive medications.
spectral outcoMes
Abnormal brain rhythms were present in all of the neuropsychiat-
ric patients. This was determined by comparing the global power 
spectra for the patients and controls. The individual power spectra 
(gray) and group mean (red) for the controls are superimposed in 
Figure 1A. Note that the dominant peak is in the alpha frequency 
range (8–12 Hz). Individual power spectra and group mean for the 
SSD, OCD, and DD patients are superimposed in Figures 1B–D, 
respectively. The difference between the control and patient groups 
is clearly seen in Figure 1E where the mean power spectra for all 
the patients and controls are superimposed. Note that the domi-
nant peak in the control group (red) is in the alpha range, while 
that for the patient group (blue) extends into the theta range, and 
that the power in beta range (12–30 Hz) is greater in the patient 
group. This difference, shown in Figure 1E, reached significance 
only in the theta band. This was largely due to the contribution of 
the OCD group as seen in Figure 1F that superimposes the mean 
power spectra for each patient group and the controls. In addi-
tion to the extension of the dominant peak to lower frequencies 
in all patient groups, note that the OCD group shows the greatest 
difference from controls in terms of power and was significantly 
larger in the theta, alpha, high beta, and gamma ranges (gamma 
not shown). Differences in MSE between other groups were not 
statistically significant in any of the five frequency bands. (The 
recordings made with the new CTF system were similar to those 
with the older system and are not discussed further).
results
clInIcal descrIptIon
The demographics and clinical description of the 29 patients are 
summarized in Table 1. The primary diagnosis (listed first in the 
Diagnosis and Symptom Domain column) was SSD in 14 patients, 
OCD in 10 patients, and major DD in 5 patients. Of those diag-
nosed with SSD, 11 had positive symptoms (hallucinations, delu-
sions), of these: two also expressed disorganized behavior, two also 
expressed negative or deficit symptoms and one also expressed 
obsessive symptoms. Three of the SSD patients had primary nega-
tive or defective symptoms. Six of the OCD patients and four of 
the SSD patients were also diagnosed with depression. Thus, most 
of the patients presented with combined, chronic neuropsychiatric 
Table 2 | Control subjects demographics.
i.d. Age (years) Gender
A001 67 M
A002 60 F
C032 27 M
C038 25 M
C046 22 M
C47 25 M
C050 25 M
C051 29 M
C101 24 F
C103 25 F
C105 27 M
C106 23 F
C108 26 F
C113 34 F
Cpd40 51 M
HT09 53 F
HT44 19 M
HT49 34 F
Table 1 | Demographics, diagnosis, medication class for 
neuropsychiatric patients.
i.d. Age Sex GAF Diagnosis and Med. or. 
 (years)   symptom domain treat
P004 45 M – DD AD
P005 62 M – OCD AD
P006 42 M 35 SSD (S1), DD AC, ADs, ATN, BZ, L
P007 35 F 65 OCD AD, BZ
P009 28 F 35 OCD, DD AD
P014 30 M 30 SSD, DD, O AC, AD, ATN, C, TN
P016 50 M 22 SSD (S1) ATN, L
P017 3 M 30 OCD, DD AD
P018 55 M 55 OCD AC, BZ
P019 42 M 45 OCD, DD AC, AD, ST
P020 31 F 35 OCD, DD AD, note 1 
P022 42 M 65 OCD, DD None
P023 24 F – OCD AD, BZ
P028 25 M 35 SSD (S1) AC, ATN
P030 31 M 40 SSD (S1), DD None
P031 35 M – OCD, DD A, AD, ATN
P041 46 M 50 SSD (S1), DD AC
P059 28 M 33 SSD (S1) AD, ATNs
P108 15 F – DD AC, ADs
P111 43 M 35 SSD (S3) ATN
P112 40 F 25 SSD (S3) ATN
P114 38 M 20 SSD (S3) None
P115 48 F – SSD (S1, S2) None
P116 39 M – SSD (S1, S2) ATN
P121 22 F – SSD (S1, S3) None
P122 48 M – DD None
P123 19 F – SSD (S1, S3) ATN
P125 60 M – DD AC, AD, L
P126 68 F – DD AC, AD
Note 1. Pt had gamma knife anterior capulatomy. Medications: A, anticholinergic; 
AD, antidepressant; AC, anticonvulsant; ATN, atypical neuroleptic; BZ, benzodia-
zepines; C, clonidine; ST, stimulant; L, lithium; TN, typical neuroleptic. Disorders: 
DD, depressive disorder; O, obsessive tendencies; OCD, obsessive–compulsive 
disorder; SSD, schizophrenic spectrum disorder. SSD Symptom Domains: S1, 
positive (hallucinations, delusions); S2, disorganized behavior (inappropriate 
affect, positive formal thought disorder, bizarre behavior); S3, primary, enduring 
negative, or deficit symptoms (diminished drive, poverty of thought, blunted 
affect, cognitive slowing).
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SSD patients (69% correct) and for DD patients (87% correct). DA 
was also applied to distinguishing between OCD and SSD patient 
groups. The most effective bands were the same as for distinguish-
ing between patients and controls; theta and gamma or low beta 
and gamma (both 75% correct).
When DA was applied using the mean band power as feature 
detectors to distinguish patients from controls, the most effective 
bands were theta (4–8 Hz) and gamma (30–70 Hz) for all patients 
(70% correct) and for OCD patients (83% correct). Low beta 
(12–18 Hz) and gamma (30–70 Hz) were the most effective for 
FiGure 1 | Multi-taper power spectra. (A–D) Individual (grey) and mean 
(±SEM) spectra for controls (red, n=18), schizophrenic spectrum disorder 
(SSD) (purple, n=14), obsessive-compulsive disorder (OCD) patients (green, 
n=10), and depression disorder (DD) (blue, n=5). (e) Superposition of mean 
(±SEM) of all patients (blue) and controls (red). (F) Superposition of means 
from A–D.
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being found in the posterior brain regions bilaterally (Figure 2C). 
The mean localization was to the mesial and posterior occipital 
cortex (Figure 2D).
Schizophrenia spectrum disorder
In the 14 SSD patients, the strongest current sources for the theta 
range ICs were consistently localized to ventromedial prefrontal cor-
tex (vmPFC; including medial aspect of the orbitofrontal cortex) 
and TP bilaterally as seen in the superposition of individual locali-
zations (Figure 3A) as well as in the mean localization (Figure 3B). 
Indeed, the figure showing the superposition of all 14 patients did not 
have any strong current sources in other brain regions (Figure 3A). 
Superposition of the current sources for alpha range activity of each 
SSD patient shows low levels of activity in various brain regions 
(Figure 3C), however, the mean localization was to the mesial and 
posterior occipital cortex (Figure 3D) as in the control group.
Obsessive–compulsive disorder
In the 10 OCD patients the strongest current sources for the theta 
range ICs were localized to vmPFC and TP bilaterally (Figures 4A,B). 
The figure showing the superposition of  localization of all 10 patients 
Ica and localIzatIon
Independent components with power in the theta frequency range 
were seen in 8 of the 18 controls and all 29 patients. Alpha range 
ICs were seen in all controls and patients. The individual locali-
zations of the components are superimposed on a standardized 
brain in Figures 2A,C–5A,C. We included this superposition so 
that the localization of each subject was illustrated. The mean 
localization is shown in Figures 2B,D–5B,D. Localization of the 
theta components is shown in Figures 2A,B–5A,B, and the alpha 
component localization is shown in Figures 2C,D–5C,D. No sta-
tistical analysis of the localizations has been attempted so these are 
exploratory findings.
Controls
Although low-frequency activity did not predominate in the overall 
power spectra of the controls (Figure 1A), there were 1–3 low-
frequency ICs in 8 of the 18 controls. Unlike the patients, these did 
not correspond to peaks in the power spectrum. These ICs were 
localized to the region of the mesial occipital cortex and left tempo-
ral pole (TP; Figures 2A,B). Alpha frequency ICs predominated in 
all the controls with superposition of the localization of these ICs 
FiGure 2 | Localization of theta and alpha band current sources in controls. 
(A) Superposition of theta range independent components (ICs) seen in 8 of the 
18 controls. Note that activity is to mesial occipital extending into the parietal 
cortex and left temporal pole (TP). (B) Mean of localizations shown in (A). This 
localization is in contrast to that for the patients in Figures 3–5. (C) Superposition 
of alpha ICs seen in all controls (10 are shown). (D) Mean of localizations shown 
in (D). Abbreviations: CS, central sulcus; L, left; mvPFC, medial ventral pre-frontal 
cortex; POS, parieto-occipital sulcus; R, right; TP, temporal pole.
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brain regions (Figure 5A). Large current sources for activity in the 
alpha frequency range were most often found in the mesial occipital 
cortex although they could also localize to the left TP (Figure 5C). 
This pattern was also present in the mean localization (Figure 5D).
dIscussIon
The present study was initiated as an attempt to contribute to the 
understanding of neuropsychiatric dysfunction via objective char-
acterization of brain electrophysiology. We used MEG to examine 
the presence of abnormal brain rhythms in patients diagnosed with 
one of three psychiatric disorders. Such abnormal rhythms were 
found to be located in brain regions previously associated with 
these psychiatric disorders. Although abnormal oscillations have 
been reported in psychiatric disorders, particularly in schizophre-
nia, the cellular mechanisms generating such oscillations are still 
largely unknown (see Marek et al., 2010). Below we offer a gen-
eral hypothesis that addresses the cellular basis of low-frequency 
showed strong currents extending from the mesial orbital frontal 
cortex (OFC) to the rostral anterior cingulate cortex (Figure 4A). 
This rostral extension was not present in the mean localization of 
this activity (Figure 4B) since it was present in only two patients. 
Current sources for activity in the alpha frequency range were wide-
spread including the midline and posterior regions as well as pre-
central gyrus and TP as seen in the superimposed images (Figure 
4C). The mean alpha localization was restricted to areas of medial 
and posterior occipital cortex (Figure 4D) as in the control group.
Depressive disorder
The strongest magnetic field generating current flow in the theta 
range in the DD patients were consistently localized to right TP in the 
superimposed (Figure 5A) and mean (Figure 5B) localization with 
stronger currents in the right than in the left TP extending laterally to 
inferior temporal cortex. Indeed, the figure showing the superposition 
of the five patients did not have any strong current sources in other 
FiGure 3 | Localization of theta and alpha band current sources in SSD 
patients. (A) Superposition of theta range independent components (ICs) for 
SSD patients. Note that activity is to bilateral medial ventral pre-frontal cortex 
(mvPFC) and bilateral temporal pole (TP). (B) Mean of localizations shown in (A). 
(C) Superposition of alpha ICs. Note localization to occipital cortex. (D) Mean of 
localizations shown in (D). Note that this is similar to that seen in the controls in 
Figure 2D. Abbreviations: CS, central sulcus; L, left; mvPFC, medial ventral 
pre-frontal cortex; POS, parieto-occipital sulcus; R, right; TP, temporal pole.
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Schizophrenia spectrum disorder
The observed mode of oscillatory pathophysiology, theta range over-
activity (Figures 1B,F), has been reported in MEG and EEG studies of 
schizophrenia. In the present study localization of theta range rhythms 
in the SSD group to vmPFC (to include the OFC) and temporal lobe 
bilaterally (Figures 3A,B) is in accordance with findings from neu-
roimaging (Goghari et al., 2010), and electrophysiological (EEG and 
MEG; Galderisi et al., 2009; Siekmeier and Stufflebeam, 2010; Uhlhaas 
and Singer, 2010) findings. Moreover, the results obtained are indeed 
very close to those reported by Holcomb et al. (2005) in which mesial 
frontal cortex and TP were imaged in a serial positron emission tomog-
raphy study in volunteers with NMDA block-induced schizophrenia. 
NMDA block has been recently shown to generate thalamic oscillatory 
behavior at theta frequency in vitro due to the deinactivation of Cav3.1 
calcium channel activity (Zhang et al., 2009). This is consistent with the 
thalamocortical hypothesis of psychiatric disorders as discussed below.
thalamocortical oscillations present in several psychiatric disorders. 
In particular, we propose that such abnormal function constitutes 
what we term a TCD (Llinas et al., 1999).
theta ranGe spontaneous rhythMIc actIvIty
Controls
Healthy individuals demonstrated a certain level of theta rhythmicity 
localized to the occipital cortex and TP (Figures 2A,B). Indeed, while 
the presence of theta range activity appears to serve as the patho-
logical focus in this study, it should be stressed that transient theta 
activity, in the ventromedial frontal cortex (vmFC) and temporal 
lobe, is not intrinsically pathological. Aside from the well-known 
theta that emanates from the hippocampal complex (Kahana et al., 
2001), mid-line frontal cortex theta activity has been associated with 
mental activity, task performance particularly for attention and work-
ing memory (Inanaga, 1998; Basar et al., 2001; Mitchell et al., 2008).
FiGure 4 | Localization of theta and alpha band current sources in OCD 
patients. (A) Superposition of theta range independent components (ICs) for 
OCD patients. Note that activity is to bilateral medial ventral pre-frontal 
cortex (mvPFC) and bilateral temporal pole (TP). (B) Mean of localizations in 
(A) show strong activity in orbital frontal cortex portion of mvPFC. (C) 
Superposition of alpha ICs that were widespread in this group of patients. 
(D) Mean of localizations shown in (C) reflecting the distributed nature of the 
localization in this chort. Abbreviations: CS, central sulcus; L, left; mvPFC, 
medial ventral pre-frontal cortex; POS, parieto-occipital sulcus; R, right; TP, 
temporal pole.
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(Fingelkurts et al., 2007; Stewart et al., 2010) making direct com-
parisons difficult. Theta range activity in these patients was most 
clearly localized to the TPs bilaterally (Figures 5A,B). In contrast 
to the SSD and OCD groups, there was little low-frequency activity 
in prefrontal areas. Projection of activity to the poles of the tem-
poral lobe may reflect activation of the nearby amygdala to which 
the OFC is connected (Kringelbach and Rolls, 2004). In depressed 
subjects, this connection is thought to be reduced (Pizzagalli et al., 
2003). Indeed, decreased inhibitory input from the rostral anterior 
cingulate and dorsal medial prefrontal cortex leads to increased 
activity of the amygdala (Drevets et al., 2008; Bennett, 2010). A 
limitation of our study is the small number of depressed patients. 
Nevertheless, these findings support a role for the presence of low-
frequency oscillations in depression.
alpha rhythMs
The alpha rhythms dominate recordings made from resting healthy 
adults with their EC (Nunez et al., 2001). This was seen in the 
control group (8–12 Hz, Figure 1A). Alpha peaks could be iden-
tified in the power spectra in most of the patients, although the 
Obsessive–compulsive disorder
The OCD group exhibited spontaneous over-activity at all fre-
quency ranges (Figures 1C,F) in agreement with a previous MEG 
study (Maihofner et al., 2007). As summarized in a recent review, 
abnormal brain activity is not unusual in OCD, and increased theta 
range activity has been reported in several studies (Clark et al., 
2009). The unambiguous localization of theta range neuromagnetic 
activity to the OFC (Figures 4A,B) is also consistent with studies 
utilizing anatomical (Chamberlain et al., 2008; Szeszko et al., 2008; 
Rotge et al., 2010b; Wobrock et al., 2010) and functional imaging 
studies (Saxena and Rauch, 2000) and EEG (Tot et al., 2002) stud-
ies. The orbitofrontal–striatal model of OCD has been reviewed in 
light of recent findings and expanded to include abnormal func-
tioning of ACC, basolateral amygdala, and hippocampus (Menzies 
et al., 2008).
Depressive disorder
The DD group also exhibited strong theta range over-activ-
ity (Figures 1D,F). The focus of EEG studies in depressed 
patients has been on asymmetries in alpha and theta rhythms 
FiGure 5 | Localization of theta and alpha band current sources in 
depressed patients. (A) Superposition of theta range independent components 
(ICs) for depressed patients. Note that activity is strongest to right temporal 
pole. (B) Mean of localizations in (A) show strong activity in right temporal pole. 
This localization differs from SSD and OCD as well as controls. (C) Superposition 
of alpha ICs to occipital cortex. (D) Mean of localizations shown in (D). 
Abbreviations: CS, central sulcus; L, left; mvPFC, medial ventral pre-frontal 
cortex; POS, parieto-occipital sulcus; R, right; TP, temporal pole.
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theta, but placebo has been shown to have the same effect (see 
Mitchell et al., 2008). Ideally, a cohort of medication naïve subjects 
would best address the issue of ongoing and long-term drug effects. 
Nevertheless, the results suggest that the critical factor in this study 
is that symptomatology correlates with aberrant neuronal activity 
in pathology-specific areas. Thus, the commonalities observed here 
and in other pathologies using MEG (Llinas et al., 1999; Schulman 
et al., 2005) may contribute toward the ongoing development of 
neurological and neuropsychiatric nosology based on physiology 
rather than subjective phenotype or phenomenology.
thalaMocortIcal dysrhythMIa Model
Viewing these results with analogous findings in other neurologi-
cal and psychiatric disorders, a common underlying mechanism 
rooted in the fundamental electrophysiological properties of the 
thalamocortical system may be conceptualized. A model has been 
proposed, TCD (Llinas et al., 1999), in which intrinsic neuronal 
properties form the substrate for disease-related physiology. In TCD 
states, persistent thalamic delta and/or theta range activity serves as 
the trigger for thalamocortical dysfunction in which a core region of 
cortex oscillates at low frequency, surrounded by an abnormal zone 
of beta or gamma band activity, an edge effect (Llinas et al., 2005).
Low-frequency thalamic oscillations are consistent with dys-
function of a well-characterized molecular target, the low-threshold 
(Cav3, T-type) Ca++ channel. At the resting potential thalamic cells 
fire tonically. However, when these neurons are hyperpolarized 
T-type calcium channels are activated and thalamic cells fire in 
low-frequency bursts. In TCD such hyperpolarization is maintained 
and low-frequency resonant recurrent interaction between tha-
lamic and cortical neurons persists disrupting normal circuit func-
tion (Llinas et al., 1998). Such low-frequency cortical oscillations 
are seen in MEG recordings, the MEG does not measure thalamic 
activity directly as is done during surgical procedures. Indeed, theta 
range neuronal activity was recorded from the thalamus of four 
subjects in this study who received stereotactic intervention that 
resulted in a decrease in localized theta activity and elimination of 
positive symptoms (Jeanmonod et al., 2001, 2003).
Thalamic neuronal hyperpolarization may occur by excess 
inhibition (Llinas and Jahnsen, 1982), by disfacilitation resulting 
from thalamic deafferentation (Llinas et al., 1998), or by block of 
excitatory ligand-gated channels (Zhang et al., 2009). The last may 
be relevant in the case of psychiatric disorders. Indeed, blocking 
NMDA receptors (NMDAR) in reticular thalamus leads to low-
frequency thalamic oscillations in brain slices (Zhang et al., 2009). 
This finding is consistent with major theories of schizophrenia; 
NMDAR hypofunction (Holcomb et al., 2005; Lindsley et al., 2006; 
Labrie and Roder, 2010), dopamine hyperfunction (Carlsson, 1977; 
Seeman, 2010), and inhibition of GABAergic neurons (Gonzalez-
Burgos et al., 2010; Jones, 2010b). It is also consistent with glutamate 
based immune hypothesis of OCD (Rotge et al., 2010a) and the 
decreased NMDA receptor efficacy in depression (Bennett, 2010).
Low-frequency rhythmic MEG activity as seen here is, we pro-
pose, the result of a functional channelopathy. Thus, chronic dein-
activation of Cav3.1 channels (Chemin et al., 2002) in thalamic 
neurons results in low-frequency spontaneous thalamic and thus 
cortical rhythmicity (Jeanmonod et al., 1996; Llinas et al., 2005; 
Jones, 2010a; Walton et al., 2010). Such a view of altered neuronal 
dominant peak was shifted to lower frequencies in some individuals 
and reduced in others (Figures 1B–D). This rhythm is reduced or 
desynchronized when attention is increased, as during a task. Such 
desynchronization may be expected in SSD and OCD patients as 
they attend to internally generated stimuli or tasks. Alpha range 
activity was localized to the occipital cortex in all patient groups and 
in the controls as illustrated in Figures 2C,D–5C,D. This activity 
was most widespread in the OCD group. Similar localization of 
alpha, but not theta activity in patient and control groups point 
to the abnormal localization of the low-frequency oscillations and 
the value of these exploratory localizations.
Beta and GaMMa rhythMs
An unambiguous and functionally significant finding concerns the 
presence of enhanced beta and gamma band activity in the OCD 
patients (Figure 1C). In six of the OCD patients ICA revealed com-
ponents with activity in the beta and/or gamma range that were 
localized to the rostral temporal cortex (not shown). Gamma band 
activity has been associated with cognitive function in human stud-
ies and has been most thoroughly studied when the oscillations are 
evoked or induced (see Woo et al., 2010).
A recent EEG study in OCD patients has reported increased cur-
rent density broadly in the beta range in frontal, parietal, and limbic 
regions (Velikova et al., 2010). Other EEG studies in OCD have 
reported decreased beta power (Karadag et al., 2003; Pogarell et al., 
2006) particularly in frontal regions. An MEG study of spontaneous 
activity found an increase in fast oscillations (12.5–30 Hz) in OCD 
patients localized to left superior temporal gyrus (Maihofner et al., 
2007). Such increases in high frequency rhythms are not commonly 
seen in psychiatric disorders. This is in contrast to gamma oscil-
lations in SSD, where deficits have been widely reported and are 
the subject of several recent reviews (Gonzalez-Burgos et al., 2010; 
Uhlhaas and Singer, 2010; Woo et al., 2010).
The increased gamma in OCD patients may reflect increased 
internally generated cognitive/hallucinatory processes. Indeed, the 
obsessive–compulsive personality, when present at a level that is 
not incapacitating, represents a human phenotype characterized 
by enhanced creativity and drive as well as the characteristics from 
which this disorder derives its name. Interestingly, this gives fur-
ther support to the functional significance of the linking of the 
emotional world with the intellectual realm. From this and other 
studies, it is clear that rhythmic brain activity is altered in several 
frequency ranges in psychiatric disorders, but a clear picture has 
not yet emerged that can be used for diagnostic purposes.
MedIcatIon effects
An important consideration in this type of study is the effect of 
medications on neuronal oscillations To examine whether the 
observed effects were a function of pharmacologic intervention, 
one OCD, one DD, and four SSD patients who were medication-
free for a period sufficiently long to assure complete drug washout 
at the time of recording were examined. No differences in the fre-
quency spectrum or localization of these subjects from the remain-
ing members of their category were observed. One patient was on 
Methylphenidate, which an EEG study found to have no effect 
on mid-line theta (Inanaga, 1998). Four patients were taking a 
benzodiazepine that has been shown to increase frontal mid-line 
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conclusIon
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